Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Heath Guay"'
Publikováno v:
Inflammatory Bowel Diseases. 29:771-782
Background Janus kinase (JAK) 1 inhibitor upadacitinib and IL-23 inhibitor risankizumab are efficacious in inflammatory bowel disease (IBD) patients who are antitumor necrosis factor (anti-TNF)-α inadequate responders (TNF-IRs). We aimed to understa
Autor:
Azucena Salas, Miriam Esteller, Ana P. Lacerda, Juan José Lozano, Lluís Revilla, Alba Garrido-Trigo, Núria Planell, J Butler, Daniel Aguilar, Heath Guay, Julián Panés, Justin W. Davis
Publikováno v:
Inflammatory Bowel Diseases
Background Janus kinase (JAK) inhibition shows promise for treatment of patients with moderate to severe Crohn’s disease. We aimed to provide mechanistic insights into the JAK1-selective inhibitor upadacitinib through a transcriptomics substudy on
Autor:
Severine Vermeire, Heath Guay, Feng Hong, Melanie Ruzek, Julián Panés, Justin W. Davis, Naim Mahi, Tariq Ahmad, James A. Butler, Alexandra Song, Xiaohong Cao, Nizar Smaoui, Nicholas A. Kennedy, Thierry Sornasse, Jasmina Kalabic, Bram Verstockt, James Fann, Valerie Pivorunas, Azucena Salas
Publikováno v:
American Journal of Gastroenterology. 116:S375-S376
Autor:
Melanie Ruzek, Xiaohong Cao, Alexandra Song, Valerie Pivorunas, Jean-Frederic Colombel, Nizar Smaoui, Feng Hong, Julián Panés, Justin W. Davis, Nael M. Mostafa, James A. Butler, Naim Mahi, Jasmina Kalabic, Heath Guay, Marc Ferrante, James Fann, Florian Rieder
Publikováno v:
American Journal of Gastroenterology. 116:S376-S376
Autor:
Simeng Lin, Mark Reppell, Neil Chanchlani, Heath Guay, M W Anderson, Nicholas A. Kennedy, James R Goodhand, B M Invergo, Tariq Ahmad, J W Butler
Publikováno v:
Journal of Crohn's and Colitis. 14:S067-S068
Background Proteomic biomarkers have been linked to anti-TNF treatment failure, but previous studies have been insufficiently powered to stratify associations by drug level. The Personalised Anti-TNF Therapy in Crohn’s disease (PANTS) is a prospect
Autor:
Heath Guay, W J Lee, Severine Vermeire, Feng Hong, J Cheng, Wen Zhou, Silvio Danese, Jesse R. Fann, Bram Verstockt, Ana P. Lacerda
Publikováno v:
Journal of Crohn's and Colitis. 14:S057-S058
Background The U-ACHIEVE trial evaluated upadacitinib (UPA), an oral JAK1 selective inhibitor, in patients with moderately to severely active ulcerative colitis (UC). Patient-reported and endoscopic outcomes improved after UPA treatment. This analysi
Autor:
Ana P. Lacerda, Severine Vermeire, James Fann, Jie Cheng, Heath Guay, Bram Verstockt, Wan-Ju Lee, Wen Zhou, Feng Hong, Silvio Danese
Publikováno v:
Gastroenterology. 158:S-1197
Autor:
Bram Verstockt, Wan-Ju Lee, Ana P. Lacerda, Silvio Danese, Heath Guay, Fabio Cataldi, Feng Hong, Vermeire Severine
Publikováno v:
American Journal of Gastroenterology. 114:S471-S471
Autor:
Subrata Ghosh, Silvio Danese, Edward V. Loftus, Heath Guay, Edouard Louis, W J Lee, F Cataldi
Publikováno v:
Journal of Crohn's and Colitis. 13:S226-S226
Autor:
Quintus G. Medley, Joe Craft, Heath Guay, Mayra Senices, Deborah Herber, Sarah A. Bertino, Sean Keegan, Tatyana A. Duzanski, Andrew L. Rankin, Nancy Stedman, Mark Ryan, Deborah Young, Laird Bloom, Kyri Dunussi-Joannopoulos, Yijun Carrier, Cheryl Nickerson-Nutter, Mary Collins
Publikováno v:
The Journal of Immunology. 188:1656-1667
MRL/MpJ-Faslpr/lpr/J (MRLlpr) mice develop lupus-like disease manifestations in an IL-21–dependent manner. IL-21 is a pleiotropic cytokine that can influence the activation, differentiation, and expansion of B and T cell effector subsets. Notably,